Lab Automation In Genomics Market Report 2026

Lab Automation In Genomics Market Overview

• Lab Automation In Genomics market size has reached to $2.68 billion in 2025 • Expected to grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Precision Medicine Propels The Genomics Lab Automation Growth • Market Trend: Revolutionizing Genomic Sequencing With Cutting-Edge Automation Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lab Automation In Genomics Market?

Lab automation in genomics refers to the use of advanced technologies and systems to streamline and automate various laboratory processes involved in genomic research and analysis. Lab automation in genomics aims to improve the efficiency, accuracy, and reproducibility of genomic research by reducing manual errors, increasing throughput, and accelerating data analysis. The main types of lab automation in genomics include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems and others. Automated liquid handlers are laboratory instruments designed to dispense precise volumes of liquids automatically, streamlining processes such as sample preparation and assay setup. These devices enhance efficiency and accuracy in genomic workflows. This is operated by several processes such as continuous automation systems and modular automation systems, for various applications, including hospitals and private labs, biotech and pharma, academics and research institutes and others.

What Is The Lab Automation In Genomics Market Growth Forecast?

The lab automation in genomics market size is expected to see rapid growth in the next few years. It will grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to increasing demand for precision medicine, rising investments in genomics infrastructure, growing adoption of ai-enabled lab automation, expansion of genomics-based clinical diagnostics, increasing focus on laboratory efficiency and cost reduction. Major trends in the forecast period include increasing adoption of fully automated genomic workflows, rising demand for high-throughput sample processing, growing integration of robotics in genomics laboratories, expansion of modular and scalable automation systems, improved reproducibility and standardization in genomic testing.

What Is The Driver Of The Lab Automation In Genomics Market?

The growing adoption of precision medicine is expected to propel the growth of lab automation in the genomics market going forward. Precision medicine is a personalized approach to healthcare that considers individual diversity in genes, environment, and lifestyle to deliver individualized medical therapies. The demand for precision medicine is rising due to several factors such as advances in genomics, targeted therapies, patient-centered care, and drug development. Precision medicine needs lots of genetic tests to find disease-related genes, pushing labs to process many samples fast and accurately, leading them to use automated systems. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the growing adoption of precision medicine is driving the growth of lab automation in the genomics market.

Key Players In The Global Lab Automation In Genomics Market

Major companies operating in the lab automation in genomics market are Thermo Fisher Scientific Inc., Tecan Group Ltd., Hamilton Company, Agilent Technologies Inc., PerkinElmer Inc., Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., QIAGEN N.V., Illumina Inc., Gilson Incorporated, Fluidigm Corporation, Beckman Coulter Life Sciences, Analytik Jena AG, LGC Biosearch Technologies, Eppendorf AG, Roche Diagnostics, Hudson Robotics, Andrew Alliance, Automata Technologies

Global Lab Automation In Genomics Market Trends and Insights

Major companies operating in lab automation in the genomics market are focused on developing advanced solutions such as automated whole genome sequencing (WGS), to significantly advance genomics research, clinical diagnostics, and personalized medicine. Automated whole genome sequencing (WGS) is sequencing an individual's genome using high-throughput, automated sequencing technologies. For instance, in May 2023, Clear Labs, Inc., a US-based genomics testing company, launched Clear Dx. This new solution provides fully automated sample processing, guaranteeing precise and consistent library preparation and management for genomics. Clear Dx automation reduces human variability and promises consistency throughout sequencing, resulting in consistent and reproducible outcomes. It streamlines genome sequencing, cutting hands-on time to just 30 minutes with a single touch point, enabling easy whole genome sequencing even without training.

What Are Latest Mergers And Acquisitions In The Lab Automation In Genomics Market?

In March 2023, INTEGRA Biosciences AG, a Switzerland-based provider of laboratory instruments and automated solutions for liquid handling, media preparation, and cell cultivation, acquired Miroculus, Inc. for an undisclosed amount. With this acquisition, INTEGRA Biosciences AG gains access to Miroculus, Inc.’s proprietary digital microfluidics technology for automating next-generation sequencing (NGS) sample preparation, thereby strengthening its genomics automation capabilities and improving its reach in advanced sequencing workflows. Miroculus, Inc. is a US-based biotechnology company specializing in digital microfluidics-powered automation for complex genomics protocols, known for its Miro Canvas platform that streamlines and simplifies NGS library preparation.

What Defines the Lab Automation In Genomics Market?

The lab automation in genomics market consists of revenues earned by entities by providing services such as sample preparation, sequencing library preparation, data analysis, sample tracking and management, quality control, customization, and integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in genomics market also includes sales of centrifuges, thermal cyclers, sequencing platforms, PCR automation systems, and robotic workstations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lab Automation In Genomics Market Report 2026?

The lab automation in genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.